#ESC25: Novartis' Leqvio cuts lipid levels, muscle pain in high-risk cholesterol patients

MADRID — Novartis’ cholesterol-cutting medicine Leqvio swiftly improved high-risk patients’ lipid levels when added to standard of care, according to data presented Saturday at the annual meeting of the European Society of Cardiology. The Phase 4 ...